Levothyroxine sodium
NDC 16729-458, Levothyroxine Sodium, tablet, from Accord Healthcare Inc..
- Product NDC
- 16729-458
- Status
- Listed
- Labeler
- Accord Healthcare Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM300 ug/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-458-15 | 16729045815 | 90 TABLET in 1 BOTTLE (16729-458-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a6233381-3043-4e9a-aaa6-a6b105e5142bNADAC price for package 16729045815
GET /v1/drugs/nadac/16729045815
Use it
Look up 16729-458 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-458. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.